Patent details

EP3349731 Title: COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3349731
PCT Application Number:
US2016052303
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168474732
PCT Publication Number:
WO2017049199
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF TOPOISOMERASE-I INHIBITORS WITH IMMUNOTHERAPY IN THE TREATMENT OF CANCER
French Title of Invention:
COMBINAISON D'INHIBITEURS DE LA TOPOISOMÉRASE-I AVEC L'IMMUNOTHÉRAPIE DANS LE TRAITEMENT DU CANCER
German Title of Invention:
KOMBINATION VON TOPOISOMERASE-I-HEMMERN MIT IMMUNTHERAPIE BEI DER BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
16/09/2016
Grant date:
01/11/2023
EP Publication Date:
25/07/2018
PCT Publication Date:
23/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
01/11/2023
EP B1 Publication Date:
01/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/09/2024
Expiration date:
16/09/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
25/10/2023
 
 

Name:
Board of Regents, The University of Texas System
Address:
210 West 7th Street, Austin, TX 78701, United States (US)

Inventor

1

Name:
AMARIA, Rodabe
Address:
United States (US)

2

Name:
MALU, Shruti
Address:
United States (US)

3

Name:
HWU, Patrick
Address:
United States (US)

4

Name:
MBOFUNG, Rina, N.
Address:
United States (US)

5

Name:
MCKENZIE, Jodi, A.
Address:
United States (US)

Priority

Priority Number:
201562219548 P
Priority Date:
16/09/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/127; A61K 39/395; A61K 31/4745; C07K 16/28; A61P 35/00; A61K 39/00; A61K 9/00;

Publication

European Patent Bulletin

Issue number:
202344
Publication date:
01/11/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages